420 related articles for article (PubMed ID: 28385388)
1. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X
Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-505 predicts prognosis and acts as tumor inhibitor in cervical carcinoma with inverse association with FZD4.
Ma C; Xu B; Husaiyin S; Wang L; Wusainahong K; Ma J; Zhu K; Niyazi M
Biomed Pharmacother; 2017 Aug; 92():586-594. PubMed ID: 28577497
[TBL] [Abstract][Full Text] [Related]
3. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
Wang N; Zhou Y; Zheng L; Li H
Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
[TBL] [Abstract][Full Text] [Related]
4. DDN-AS1-miR-15a/16-TCF3 feedback loop regulates tumor progression in cervical cancer.
Liu Z; Wu M; Shi H; Huang C; Luo S; Song X
J Cell Biochem; 2019 Jun; 120(6):10228-10238. PubMed ID: 30582201
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer.
Zhang H; Yan T; Liu Z; Wang J; Lu Y; Li D; Liang W
J Cell Biochem; 2018 Jan; 119(1):938-947. PubMed ID: 28681918
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L
J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
Qin X; Wan Y; Wang S; Xue M
Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
Luo M; Shen D; Zhou X; Chen X; Wang W
Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of Transcription Factor 3 Is Correlated With Poor Prognosis in Cervical Carcinoma.
Luo L; Zhang H; Nian S; Lv C; Ni B; Wang D; Tian Z
Int J Gynecol Cancer; 2017 Sep; 27(7):1422-1430. PubMed ID: 28604457
[TBL] [Abstract][Full Text] [Related]
11. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer.
Wang LQ; Zhang Y; Yan H; Liu KJ; Zhang S
Biochem Biophys Res Commun; 2015 Apr; 459(3):515-20. PubMed ID: 25747718
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.
Yu Y; Liu L; Ma R; Gong H; Xu P; Wang C
Tumour Biol; 2016 Oct; 37(10):14249-14257. PubMed ID: 27571739
[TBL] [Abstract][Full Text] [Related]
14. MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer.
Pang H; Yue X
Tumour Biol; 2017 Jun; 39(6):1010428317701308. PubMed ID: 28651495
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7.
Deng B; Zhang Y; Zhang S; Wen F; Miao Y; Guo K
Tumour Biol; 2015 Sep; 36(10):8065-73. PubMed ID: 25976503
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
18. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
[TBL] [Abstract][Full Text] [Related]
19. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
[TBL] [Abstract][Full Text] [Related]
20. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L
BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
